Articles dans des revues avec comité de lecture (31)
1.
Smeesters, P., De Crombrugghe De Looringhe, G., Tsoi, S. K., Leclercq, C., Baker, C. A., Osowicki, J., Botteaux, A., & Steer, A. C. (2023). Global systematic review of group A streptococcal disease – worldwide vaccine priorities and tissue tropism. The Lancet Microbe.2.
Smeesters, P., de Crombrugghe, G., Tsoi, S. K., Leclercq, C., Baker, C. A., Osowicki, J., Verhoeven, C., Botteaux, A., & Steer, A. C. (2024). Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review. The Lancet Microbe, 5(2), e181-e193. doi:10.1016/S2666-5247(23)00318-X3.
Proctor, E. J., Frost, H. R. C. H., Satapathy, S., Botquin, G., Urbaniec, J., Gorman, J., De Oliveira, D. M. P., McArthur, J., Davies, M. M., Botteaux, A., Smeesters, P., & Sanderson-Smith, M. L. (2024). Molecular characterization of the interaction between human IgG and the M-related proteins from Streptococcus pyogenes. The Journal of biological chemistry, 300(2), 105623. doi:10.1016/j.jbc.2023.1056234.
Armitage, E. P., de Crombrugghe, G., Keeley, A. R. A., Senghore, E., Camara, F., Jammeh, M., Bittaye, A., Ceesay, H., Ceesay, I., Samateh, B., Manneh, M., Kampmann, B., Turner, C. C., Kucharski, A. A., Botteaux, A., Smeesters, P., De Silva, T. T., Marks, M., Sesay, A. K., Bah, S., Erhart, A., Roca, A., Tiencheu, P. E., Jabang, S., Darboe, S., Antonio, M., Jaiteh, L., & Forrest, K. (2024). Streptococcus pyogenes carriage and infection within households in The Gambia: a longitudinal cohort study. The Lancet Microbe. doi:10.1016/S2666-5247(24)00046-65.
Remy, A., Zveny, J., Serra, T., Lakhloufi, D., Bourgeois, A., Devière, J., Botteaux, A., Delchambre, A., Reniers, F., & Nonclercq, A. (2024). Pseudomonas aeruginosa biofilm decontamination and removal by Ar/H2O cold atmospheric plasma in endoscope-like tubing. Journal of physics. D, Applied physics.6.
Schiavolin, L., Deneubourg, G., Steinmetz, J., Smeesters, P. R., & Botteaux, A. (2023). Group A Streptococcus adaptation to diverse niches: lessons from transcriptomic studies. Critical reviews in microbiology, 1-25. doi:10.1080/1040841X.2023.22949057.
Zangarini, L., Martiny, D., Miendje Deyi, Y. V., Hites, M., Maillart, E., Hainaut, M., Delforge, M.-L., Botteaux, A., Matheeussen, V., Goossens, H., Hallin, M., Smeesters, P., & Dauby, N. (2023). Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels-Capital Region, 2005–2020. European journal of clinical microbiology & infectious diseases, 42(5), 555-567. doi:10.1007/s10096-023-04568-y8.
Frost, H., Guglielmini, J., Duchêne, S., Lacey, J. A., Sanderson-Smith, M. L., Steer, A. C., Walker, M. J., Botteaux, A., Davies, M. R., & Smeesters, P. (2023). Promiscuous evolution of Group A Streptococcal M and M-like proteins. Microbiology, 169(1). doi:10.1099/mic.0.0012809.
Kteily, K., Pening, D., Diaz Vidal, P., Devos, M., Dechene, J., Op De Beeck, A., Botteaux, A., Janssens, S., Van den Abbeel, E., Goldrat, O., Delbaere, A., & Demeestere, I. (2021). Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART. Human reproduction. doi:10.1093/humrep/deab25510.
Aranha, M. M., Penfound, T. T., Salehi, S., Botteaux, A., Smeesters, P., Dale, J. B., & Smith, J. (2021). Design of Broadly Cross-Reactive M Protein–Based Group A Streptococcal Vaccines. The Journal of immunology, 207(4), 1138-1149. doi:10.4049/jimmunol.210028611.
Laho, D., Blumental, S., Botteaux, A., & Smeesters, P. (2021). Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis. Frontiers in Pediatrics, 9, 697938. doi:10.3389/fped.2021.69793812.
Jabang, S., Erhart, A., Darboe, S., Baldeh, A. K., Delforge, V., Watson, G., Foster-Nyarko, E., Salaudeen, R., Lawal, B., Mackenzie, G., Botteaux, A., Antonio, M., & Smeesters, P. (2021). Molecular Epidemiology of Group A Streptococcus Infections in The Gambia. Vaccines, 9(2), 124. doi:10.3390/vaccines9020124